Glaxosmithkline Pharma net profit declines 42.88% in the March 2014 quarter

Sales decline 5.11% to Rs 599.85 crore

Net profit of Glaxosmithkline Pharma declined 42.88% to Rs 96.54 crore in the quarter ended March 2014 as against Rs 169.01 crore during the previous quarter ended March 2013. Sales declined 5.11% to Rs 599.85 crore in the quarter ended March 2014 as against Rs 632.14 crore during the previous quarter ended March 2013. ParticularsQuarter EndedMar. 2014Mar. 2013% Var.Sales599.85632.14 -5 OPM %17.9426.52 -PBDT152.48244.58 -38 PBT148.23240.41 -38 NP96.54169.01 -43

Powered by Capital Market - Live News